Cargando…
A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma
BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most common type of head and neck squamous cell carcinoma with an unsatisfactory prognosis. The aim of this study was to identify potential prognostic mRNA biomarkers of OSCC based on analysis of The Cancer Genome Atlas (TCGA). METHODS: Expressi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679650/ https://www.ncbi.nlm.nih.gov/pubmed/31396442 http://dx.doi.org/10.7717/peerj.7360 |
_version_ | 1783441380770578432 |
---|---|
author | Cao, Ruoyan Wu, Qiqi Li, Qiulan Yao, Mianfeng Zhou, Hongbo |
author_facet | Cao, Ruoyan Wu, Qiqi Li, Qiulan Yao, Mianfeng Zhou, Hongbo |
author_sort | Cao, Ruoyan |
collection | PubMed |
description | BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most common type of head and neck squamous cell carcinoma with an unsatisfactory prognosis. The aim of this study was to identify potential prognostic mRNA biomarkers of OSCC based on analysis of The Cancer Genome Atlas (TCGA). METHODS: Expression profiles and clinical data of OSCC patients were collected from TCGA database. Univariate Cox analysis and the least absolute shrinkage and selection operator Cox (LASSO Cox) regression were used to primarily screen prognostic biomarkers. Then multivariate Cox analysis was performed to build a prognostic model based on the selected prognostic mRNAs. Nomograms were generated to predict the individual’s overall survival at 3 and 5 years. The model performance was assessed by the time-dependent receiver operating characteristic (ROC) curve and calibration plot in both training cohort and validation cohort (GSE41613 from NCBI GEO databases). In addition, machine learning was used to assess the importance of risk factors of OSCC. Finally, in order to explore the potential mechanisms of OSCC, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was completed. RESULTS: Three mRNAs (CLEC3B, C6 and CLCN1) were finally identified as a prognostic biomarker pattern. The risk score was imputed as: (−0.38602 × expression level of CLEC3B) + (−0.20632 × expression level of CLCN1) + (0.31541 × expression level of C6). In the TCGA training cohort, the area under the curve (AUC) was 0.705 and 0.711 for 3- and 5-year survival, respectively. In the validation cohort, AUC was 0.718 and 0.717 for 3- and 5-year survival. A satisfactory agreement between predictive values and observation values was demonstrated by the calibration curve in the probabilities of 3- and 5- year survival in both cohorts. Furthermore, machine learning identified the 3-mRNA signature as the most important risk factor to survival of OSCC. Neuroactive ligand-receptor interaction was most enriched mostly in KEGG pathway analysis. CONCLUSION: A 3-mRNA signature (CLEC3B, C6 and CLCN1) successfully predicted the survival of OSCC patients in both training and test cohort. In addition, this signature was an independent and the most important risk factor of OSCC. |
format | Online Article Text |
id | pubmed-6679650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66796502019-08-08 A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma Cao, Ruoyan Wu, Qiqi Li, Qiulan Yao, Mianfeng Zhou, Hongbo PeerJ Bioinformatics BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most common type of head and neck squamous cell carcinoma with an unsatisfactory prognosis. The aim of this study was to identify potential prognostic mRNA biomarkers of OSCC based on analysis of The Cancer Genome Atlas (TCGA). METHODS: Expression profiles and clinical data of OSCC patients were collected from TCGA database. Univariate Cox analysis and the least absolute shrinkage and selection operator Cox (LASSO Cox) regression were used to primarily screen prognostic biomarkers. Then multivariate Cox analysis was performed to build a prognostic model based on the selected prognostic mRNAs. Nomograms were generated to predict the individual’s overall survival at 3 and 5 years. The model performance was assessed by the time-dependent receiver operating characteristic (ROC) curve and calibration plot in both training cohort and validation cohort (GSE41613 from NCBI GEO databases). In addition, machine learning was used to assess the importance of risk factors of OSCC. Finally, in order to explore the potential mechanisms of OSCC, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was completed. RESULTS: Three mRNAs (CLEC3B, C6 and CLCN1) were finally identified as a prognostic biomarker pattern. The risk score was imputed as: (−0.38602 × expression level of CLEC3B) + (−0.20632 × expression level of CLCN1) + (0.31541 × expression level of C6). In the TCGA training cohort, the area under the curve (AUC) was 0.705 and 0.711 for 3- and 5-year survival, respectively. In the validation cohort, AUC was 0.718 and 0.717 for 3- and 5-year survival. A satisfactory agreement between predictive values and observation values was demonstrated by the calibration curve in the probabilities of 3- and 5- year survival in both cohorts. Furthermore, machine learning identified the 3-mRNA signature as the most important risk factor to survival of OSCC. Neuroactive ligand-receptor interaction was most enriched mostly in KEGG pathway analysis. CONCLUSION: A 3-mRNA signature (CLEC3B, C6 and CLCN1) successfully predicted the survival of OSCC patients in both training and test cohort. In addition, this signature was an independent and the most important risk factor of OSCC. PeerJ Inc. 2019-07-31 /pmc/articles/PMC6679650/ /pubmed/31396442 http://dx.doi.org/10.7717/peerj.7360 Text en ©2019 Cao et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Bioinformatics Cao, Ruoyan Wu, Qiqi Li, Qiulan Yao, Mianfeng Zhou, Hongbo A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma |
title | A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma |
title_full | A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma |
title_fullStr | A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma |
title_full_unstemmed | A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma |
title_short | A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma |
title_sort | 3-mrna-based prognostic signature of survival in oral squamous cell carcinoma |
topic | Bioinformatics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679650/ https://www.ncbi.nlm.nih.gov/pubmed/31396442 http://dx.doi.org/10.7717/peerj.7360 |
work_keys_str_mv | AT caoruoyan a3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT wuqiqi a3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT liqiulan a3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT yaomianfeng a3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT zhouhongbo a3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT caoruoyan 3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT wuqiqi 3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT liqiulan 3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT yaomianfeng 3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma AT zhouhongbo 3mrnabasedprognosticsignatureofsurvivalinoralsquamouscellcarcinoma |